亞太絲路投資(00767.HK)恢復公眾持股量
格隆匯3月25日丨亞太絲路投資(00767.HK)發佈公告,董事會獲要約人告知,要約人已於2020年3月24日於公開市場出售1300萬股股份(相當於公司全部已發行股本約0.34%),以恢復公司公眾持股量。出售事項完成後,要約人及與其一致行動人持股量已減少至2,902,127,526股股份(相當於公司全部已發行股本約74.99%)。
公告稱,緊隨出售事項後及於該公告日期,有967,975,124股股份為由公眾持有,相當於公司全部已發行股本約25.01%。因此,公司最低公眾持股量經已恢復,故公司已符合上市規則第8.08(1)(a)條規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.